https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:5008 Wed 11 Apr 2018 14:04:57 AEST ]]> Treatment combinations targeting apoptosis to improve immunotherapy of melanoma https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:6917 Wed 11 Apr 2018 09:56:34 AEST ]]> A systematic scoping review on natural killer cell function in colorectal cancer https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46186 Tue 15 Nov 2022 08:43:55 AEDT ]]> Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:219 Tue 10 Sep 2024 16:17:27 AEST ]]> Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48634 3.5-fold after steroid and ATG treatment. This case illustrates the need to consider this form of steroid resistance in patients failing treatment with corticosteroids. It also highlights the need for both better identification of patients at risk and the development of treatments that involve more specific immune suppression.]]> Mon 03 Apr 2023 10:14:28 AEST ]]>